Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1939-4551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study ; volume:11 ; number:1 ; day:1 ; month:11 ; year:2018 ; pages:1-11 ; date:12.2018
World Allergy Organization journal / World Allergy Organization ; 11, Heft 1 (1.11.2018), 1-11, 12.2018
- Urheber
-
Canonica, Giorgio W.
Rottoli, Paola
Bucca, Caterina
Zappa, Maria Cristina
Michetti, Giovanni
Macciocchi, Bruno
Caruso, Cristiano
Santus, Pierachille
Bartezaghi, Marta
Rigoni, Laura
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40413-018-0214-3
- URN
-
urn:nbn:de:101:1-2018122023370082101984
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Canonica, Giorgio W.
- Rottoli, Paola
- Bucca, Caterina
- Zappa, Maria Cristina
- Michetti, Giovanni
- Macciocchi, Bruno
- Caruso, Cristiano
- Santus, Pierachille
- Bartezaghi, Marta
- Rigoni, Laura
- SpringerLink (Online service)
Ähnliche Objekte (12)
Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
Journal of patient-reported outcomes
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
Patient-reported barriers to osteoporosis therapy
Patient-reported outcomes in heart failure
Patient-Reported Symptoms after Midfacial Trauma
Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
Journal of patient-reported outcomes
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
Patient-reported barriers to osteoporosis therapy
Patient-reported outcomes in heart failure
Patient-Reported Symptoms after Midfacial Trauma
Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
Journal of patient-reported outcomes
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
Patient-reported barriers to osteoporosis therapy
Patient-reported outcomes in heart failure